The Year in Biotech and What’s Ahead in 2023
The Bio Report
00:00
Is Biogen Going to Move Beyond Its MS Franchise?
This is a company that's struggled to move beyond its MS franchise. Is there a reason to think activity will pick up in 2023? That's the perennial question, right? You ask everybody, like, what do you think M&A activity will be in the next 12 months? And the answer to those survey questions is always there will be more, right? But does that necessarily mean that we'll see deals? Like, who knows?"
Transcript
Play full episode
